Group 1 - Jinli Permanent Magnet expects a net profit of 660 million to 760 million yuan for 2025, representing a year-on-year growth of 127% to 161% [1] - Wens Foodstuffs anticipates a net profit of 5 billion to 5.5 billion yuan for 2025, a decrease of 40.73% to 46.12% compared to the previous year [2] - New Open Source plans to repurchase shares worth 40 million to 50 million yuan, with a maximum repurchase price of 25.77 yuan per share [3] Group 2 - Fosun Pharma's subsidiary has had a drug registration application accepted for a new drug targeting ALK-positive non-small cell lung cancer [4] - Leike Film reported a net profit of -86 million yuan for the first three quarters of 2025, indicating a potential annual loss [5] - Crown Stone Technology's application for a specific issuance of A-shares has been accepted by the Shanghai Stock Exchange [6] Group 3 - Dongxin Technology has completed the business registration change for its subsidiary, Lishuan Technology, and has invested 211 million yuan in it [7] - Tianci Materials has increased its commodity futures hedging business limit from 150 million to 300 million yuan [8] - Gaode Infrared's actual controller has reduced his shareholding by 0.54%, bringing his stake down to 62.95% [9] Group 4 - Tianyong Intelligent expects a net profit of 10 million to 15 million yuan for 2025, marking a turnaround from losses [10][11] - China Merchants Energy anticipates a net profit of 6 billion to 6.6 billion yuan for 2025, an increase of 17% to 29% year-on-year [18] - Guangdong Electric Power A's Huizhou Power Plant's Unit 5 has been put into commercial operation, with an investment of 8.05 billion yuan [19] Group 5 - Jianghuai Automobile reported a 42.24% year-on-year increase in sales volume for December 2025 [25] - China Pharmaceutical's subsidiary has received a drug registration certificate for a new medication [26] - TianNeng Co. plans to use up to 12 billion yuan of its own funds for entrusted wealth management [27] Group 6 - Luoyang Huizhong reported a 10.55% month-on-month decrease in sales revenue from live pigs for December 2025 [28] - Baolidi expects a net profit of 145 million to 152 million yuan for 2025, a year-on-year increase of 27.17% to 33.30% [30] - Changchun High-tech's subsidiary has had a melatonin granule registration application accepted [31] Group 7 - Zhongmin Energy reported a 4.46% year-on-year decrease in cumulative on-grid electricity for 2025 [32] - Huaxin Electronics reported a 7.79% year-on-year decrease in consolidated operating revenue for December 2025 [35] - Xiamen Airport reported a 2.79% year-on-year increase in passenger throughput for December 2025 [36] Group 8 - Baiyun Airport reported a 12.27% year-on-year increase in passenger throughput for December 2025 [37] - Pulaike has received a new veterinary drug registration certificate for a chewable tablet [38] - Yunnan Energy Holdings' subsidiary has reduced its stake to 84% after a capital increase [39] Group 9 - Gansu Energy Chemical's new thermal power project has successfully completed trial operation [41] - Zhenghong Technology reported a significant decrease in sales revenue from live pigs for December 2025 [42] - Huasheng Lithium Battery is planning to issue H-shares for listing on the Hong Kong Stock Exchange [43] Group 10 - Jincheng Mining has signed a mining production contract with an estimated total price of approximately 510 million yuan [44] - Microchip Biotech has received approval for clinical trials of a new drug for pancreatic cancer [45] - Yahon Pharmaceutical has completed the first patient enrollment for a Phase I clinical trial of its drug [46]

证券代码：605050 证券简称：福然德 公告编号：2026-001 福然德股份有限公司 关于控股股东、实际控制人的一致行动人 暨持股 5%以上股东减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 股东持股的基本情况：本次减持主体为福然德股份有限公司（以下简称 "公司"）控股股东、实际控制人的一致行动人暨持股 5%以上股东宁波人科创业 投资合伙企业（有限合伙）（以下简称"人科合伙"）。本次减持计划实施前，人 科合伙持有公司无限售条件流通股 123,750,000 股，占公司总股本的 25.11%， 股份来源为公司首次公开发行前取得，该部分股份已于 2023 年 9 月 25 日解除限 售并上市流通。 减持计划的主要内容：公司于 2025 年 12 月 2 日披露了《福然德股份有 限公司关于控股股东、实际控制人的一致行动人暨持股 5%以上股东减持股份计 划的公告》（公告编号：2025-054）。因自身资金需求，人科合伙拟于 2025 年 12 月 24 日至 2026 年 3 月 23 ...

Core Viewpoint - The company Furan De (605050.SH) has completed a share reduction plan executed by its shareholder Renke Partnership, resulting in a total reduction of 14.7847 million shares, which accounts for 3.00% of the company's total share capital [1] Summary by Category - **Share Reduction Details** - Renke Partnership reduced its holdings from December 29, 2025, to January 8, 2026, through block trading, selling 9.8565 million shares, which is 2.00% of the total share capital [1] - Additionally, Renke Partnership sold 4.9282 million shares through centralized bidding, representing 1.00% of the total share capital [1] - **Completion of Reduction Plan** - The total shares reduced by Renke Partnership amounted to 14.7847 million, completing the planned reduction [1]

Group 1 - The controlling shareholder and actual controller's concerted action partner, Ningbo Renke Venture Capital Partnership, plans to reduce its holdings by a total of 3.00% from December 29, 2025, to January 8, 2026 [1] - The reduction will occur through block trading and centralized bidding, with a total of shares being sold [1] - The selling price range is between 11.93 yuan and 13.88 yuan per share, amounting to a total of billion yuan [1] Group 2 - After the reduction, Renke Partnership's shareholding ratio will decrease to 22.11% [1]

福然德股份有限公司 2026 年第一次临时股东会会议资料 1 / 9 福然德股份有限公司 2026 年第一次临时股东会会议资料 福然德股份有限公司 2026 年第一次临时股东会会议须知 福然德股份有限公司 2026 年第一次临时股东会 会议资料 中国•上海 2025 年 12 月 五、出席本次大会的股东依法享有发言权、质询权、表决权等股东权利。股 东需要在股东会发言的，应于会议开始前至少十五分钟，在登记处登记，出示有 效的持股证明，填写"发言登记表"，由公司统一安排按登记顺序发言。每位股 东发言应围绕本次会议议题，简明扼要，时间原则上不超过 3 分钟，以便给予其 他股东更多发言机会。公司董事、监事和高管人员对于股东的提问将认真作出答 复和解释。股东不得无故中断股东会议程要求发言。本次会议在进行表决时，股 东及股东代表不可进行大会发言。 六、对股东及股东代表提出的问题，由主持人指定相关人员作出答复或者说 明。对于涉及公司商业秘密的提问，会议主持人或相关负责人将在保密的基础上 尽量说明。 2 / 9 福然德股份有限公司 2026 年第一次临时股东会会议资料 二、为保证本次会议的正常秩序，除出席会议的股东及股东代表 ...

| 权益变动方向 | 比例增加□ | | 比例减少☑ | | --- | --- | --- | --- | | 权益变动前合计比例 | 55.52% | | | | 权益变动后合计比例 | 55.00% | | | | 本次变动是否违反已作出的承 诺、意向、计划 | 是□ | 否☑ | | | 是否触发强制要约收购义务 | 是□ | 否☑ | | 证券代码：605050 证券简称：福然德 公告编号：2025-062 福然德股份有限公司 关于控股股东、实际控制人的一致行动人暨持股 5% 以上股东权益变动触及 1%、5%刻度暨披露简式权益变 动报告书的提示性公告 公司控股股东、实际控制人的一致行动人暨持股 5%以上股东宁波人科创业投资合 伙企业（有限合伙）（以下简称"人科合伙"）保证向本公司提供的信息真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： 一、 信息披露义务人及其一致行动人的基本信息 1.身份类别 | | ☑控股股东/实际控制人及其一致行动人 | | --- | --- | | | □其他 5%以上大股东及其一 ...

福然德股份有限公司简式权益变动报告书 福然德股份有限公司 简式权益变动报告书 上市公司名称：福然德股份有限公司 股票上市地点：上海证券交易所主板 权益变动性质：股份减少，触及 5%刻度 股票简称：福然德 股票代码：605050 信息披露义务人：宁波人科创业投资合伙企业（有限合伙） 经营场所：浙江省宁波保税南区曹娥江路 16 号 1 幢 1 楼 119 室 通讯地址：浙江省宁波保税南区曹娥江路 16 号 1 幢 1 楼 119 室 信息披露义务人的一致行动人：崔建华 住所地址：上海市宝山区****** 通讯地址：上海市宝山区富桥路 55 号东楼 10 楼 信息披露义务人的一致行动人：崔建兵 住所地址：上海市宝山区****** 通讯地址：上海市宝山区富桥路 55 号西楼 10 楼 签署日期：2025 年 12 月 31 日 1 福然德股份有限公司简式权益变动报告书 信息披露义务人及其一致行动人声明 一、信息披露义务人及其一致行动人依据《中华人民共和国公司法》、《中 华人民共和国证券法》、《上市公司收购管理办法》、《公开发行证券的公司信息 披露内容与格式准则第 15 号--权益变动报告书》等相关的法律、法规和规范性 ...

本次权益变动前，信息披露义务人人科合伙及其一致行动人合计持有公司股份比例55.52%；本次权益 变动后,人信息披露义务人人科合伙及其一致行动人合计持有公司股份比例55.00%。综上，信息披露义 务人人科合伙及其一致行动人合计持有公司股份比例由55.52%减少至55.00%，权益变动同时触及1%及 5%刻度。 格隆汇12月31日丨福然德(605050.SH)公布，公司于近日收到公司控股股东、实际控制人的一致行动人 暨持股5%以上股东宁波人科创业投资合伙企业（有限合伙）发来的《关于权益变动比例触及1%和5%刻 度的告知函》以及《简式权益变动报告书》，人科合伙于2025年12月30日至2025年12月31日期间，通过 集合竞价交易方式减持公司股份259.74万股，占公司总股本的0.52%。 ...

Core Viewpoint - The company Furan De (605050.SH) has reported a reduction in shareholding by its major shareholder, Ningbo Renke Venture Capital Partnership, which has decreased its stake from 55.52% to 55.00% through the sale of 2.5974 million shares, representing 0.52% of the total share capital [1] Group 1 - The major shareholder, Ningbo Renke Venture Capital Partnership, reduced its holdings by 2.5974 million shares [1] - The reduction in shareholding occurred between December 30, 2025, and December 31, 2025 [1] - The total shareholding percentage of the major shareholder and its concerted parties decreased from 55.52% to 55.00% [1]

南财智讯12月31日电，福然德公告，宁波人科创业投资合伙企业（有限合伙）及其一致行动人崔建华、 崔建兵因自身资金需求，通过大宗交易和集中竞价交易方式合计减持公司股份12,453,900股，占公司总 股本的2.52%。本次权益变动后，信息披露义务人及其一致行动人合计持有公司股份271,056,100股，持 股比例由57.52%降至55.00%。本次减持未导致公司控股股东、实际控制人发生变化，所持股份均为无 限售流通股，不存在质押、冻结等权利限制情况。上述减持计划尚未实施完毕，未来将继续按规定履行 信息披露义务。 ...